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Summary
Extracorporeal membrane oxygenation (ECMO) and ex-
tracorporeal life support (ECLS) have been around for a
long time, but it is only in recent years, with the advent
of acute respiratory distress syndrome consecutive to influ-
enza A (H1N1) infection, that these life-saving technolo-
gies have seen a broader application. Although the results
of ECLS and ECMO are perceived as generally encour-
aging, there are still disturbing complications related to
peripheral cannulation in general and, more specifically,
to cannulation in the groin. The present review was de-
signed to assess the magnitude of this latter problem, i.e.
leg ischaemia related to ECLS and ECMO, in the literature
and to identify strategies for possible therapies and, more
importantly, prevention.
The search strategy selected identified seven original art-
icles with more than twenty patients, totalling 407 patients
who underwent veno-arterial ECMO, and one large review
dealing with all kinds of complications. For the original
reports, the number of cases with veno-arterial support
ranged from 21 to 143, with, as far as available, frequency
of ischaemic complications between 11% and 52%, a re-
ported range of surgical intervention between 9% and 22%,
and a leg amputation rate from 2% to 10%. It appears
that the number of reports dealing with lower extremity
ischaemia during ECMO increases in parallel with the
number of reports about ECMO. Strategies for early de-
tection of peripheral ischaemia, interventions for efficient
reperfusion, and measures for prevention including new
concepts with smaller and eventually bidirectional arterial
cannulas are discussed.
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Introduction
Although the pump-oxygenator was initially conceived for
supporting the failing lungs [1], its main application became
temporary cardiorespiratory support enabling open surgery
on the arrested heart. Problems thereafter naturally prompted
its short-term use for supporting the failing heart and lungs.
It is since the 1970s that extracorporeal membrane oxygen-
ation (ECMO) and extracorporeal life support (ECLS) came
along [2, 3] as stand-alone procedures, but it is only in recent
years with the advent of acute respiratory distress syndrome
consecutive to influenza A (H1N1) infection [4] that these
life-saving technologies [5] have seen a broader application.
As outlined above, there are basically three indications for
extracorporeal life support with a pump-oxygenator: severe
respiratory failure, severe cardiac failure, and cardiorespir-
atory failure. The preferred approach for essentially respir-
atory failure is veno-venous ECMO providing additional
extrapulmonary gas transfer for both O2 and CO2. This ap-
proach has the advantage of requiring vascular access on the
low pressure venous side only and can usually be realised
with peripheral venous cannulation [6]. By definition, there
is no circulatory support with veno-venous ECMO. For as-
sisting the failing heart with a pump oxygenator, veno-ar-
terial ECLS is preferred. Although a pump alone is suffi-
cient to provide flow, access to either the isolated pulmonary
circulation or the isolated systemic circulation is technically
demanding, and therefore veno-arterial ECLS allowing for
peripheral venous drainage and peripheral arterial return is
usually applied outside of the operating theatre [6]. Overall,
the results of ECLS and ECMO are perceived as generally
encouraging [7], but there are still disturbing complications
related to peripheral cannulation in general and, more spe-
cifically, to cannulation in the groin. The present review was
designed to assess the magnitude of this latter problem – leg
ischaemia related to ECLS and ECMO – in the literature and
to identify strategies for possible therapies and more import-
antly, prevention.
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 1 of 9
Materials and methods
A PubMed search was realised on April 26, 2015 with the
following search terms:
– ECLS limb ischemia
– ECLS amputation
– ECMO limb ischemia
– ECMO amputation
A list with the most pertinent reports, including more than
20 patients and related to the issues raised here, can be
found in table 1.
Recommendations for treatment of limb ischaemia related
to ECLS and ECMO were extracted from the papers men-
tioned in table 1, other pertinent reports in the literature
and the clinical experience of the co-authors. The same ap-
proach was used to identify hints for prevention of limb
ischaemia related to ECLS and ECMO.
Limb ischaemia and amputation
related to ECLS and ECMO
ECLS and limb ischaemia
The PubMed search described above provided seven hits
for the search term “ECLS limb ischemia”. The first pub-
lication appeared in February 1996 and the last one in July
2014. Typically, there was one publication every 3 years.
However, there was no hit at all for the search term “ECLS
amputation”.
Figure 1
Number of reports on limb ischaemia and amputation in relation to
extracorporeal membrane oxygenation (ECMO).
ECMO and limb ischaemia
A somewhat different picture appeared for the search term
“ECMO limb ischemia” with 67 hits, the first one in July
1995 and the last one in April 2015, or typically two public-
ations per year (fig. 1). There were also more reports with
the search term “ECMO amputation” than with the corres-
ponding search for ECLS, with 28 hits, the first one be-
ing from November 2008 and the last one from April 2015.
For recent years there were up to five publications per year
about amputation in the context of ECMO.
The most pertinent reports on ECMO and limb ischaemia
are shown in table 1. It turns out that limb ischaemia is es-
sentially reported in studies reporting results for veno-ar-
terial perfusion in ECLS or ECMO. There is also a more
general review about ECLS and ECMO by Cheng and col-
leagues including all types of complications (see below).
For the original reports listed here the number of cases with
veno-arterial support ranged from 21 to 143, with, as far as
available, a frequency of ischaemic complications between
11% and 52%, a reported rate of surgical intervention of
between 9% and 22%, and a leg amputation rate ranging
from 2% to 10%.
The review by Cheng et al. [15] mentioned above focused
on complications of ECMO for cardiogenic shock and in-
cluded 20 studies with more than 10 patients after the year
2000. The authors compiled a total of 1866 cases with a
survival of 534/1529 patients or 35% (range 20.8–65.4%).
The most frequent complications observed in this setting
were acute kidney injury (55.6%), bleeding (40.8%), major
infection (30.4%) and neurological deficits (13.3%). Lower
extremity ischaemia occurred in 16.9% (range
12.5–22.6%), compartment syndrome and fasciotomy ac-
counted for 10.3% (range 7.3–14.5%), and lower extremity
amputation was required in 4.7% (range 2.3–9.3%). The
latter finding is very much in line with the seven studies
from the current searches listed in table 1, where the lower
extremity amputation rate was 2% to 10%.
Although ranking only fourth in frequency of the most fre-
quent complications observed, lower extremity ischaemia
related to ECLS and ECMO is a very serious problem, res-
ulting most of the time in compartment syndrome and fas-
ciotomy with a high risk for a functional deficit or an am-
putation which is mutilating at best, and eventually carries
a high risk for a lethal outcome.
Table 1: Key references including more than twenty patients drawn from Pub Med for lower extremity ischaemia in veno-arterial extracorporeal membrane oxygenation
(ECMO) with peripheral cannulation.
Ref. no. Year Author v-a ECMO n Ischaemia Surgery Amputation
[8] 2010 Foley, et al. 43 7 4 1 (2%)
[9] 2010 Gander, et al. (paediatric) 21 11 (52%) 2 (10%)
[10] 2011 Bisdas, et al. 143 15 (11%) 2 (1%)
[11] 2013 Guo, et al. 26 8 (31%) 6 (22%) 2 (8%)
[12] 2013 Deschka, et al. (central) 28 1 (4%)
[13] 2014 Mohite, et al. 45 9 (20%) 4 (9%) 1 (2%)
[14] 2014 Aziz F, et al. 101 18 16 1
[15] 2014 Cheng, et al. (review) 1866 (16.9%) (4.7%)
v-a ECMO n = number of patients with veno-arterial ECMO
Ischaemia = number of patients (%) with lower extremity ischaemia
Surgery = number of patients (%) requiring surgery for lower extremity ischaemia
Amputation = number of patients (%) requiring lower extremity amputation
Note: n and (%) values given are cited from the references given.
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Diagnosis of limb ischaemia related to
ECLS and ECMO
It is good clinical practice to verify that there is sufficient
distal perfusion after insertion of arterial and/or venous
cannulas into the femoral vessels by making sure that ad-
equate pulses are present at the level of the dorsalis pedis
artery as well as the posterior tibial artery of the lower ex-
tremities involved on one side, and that no signs of venous
stasis are present on the other. However, in the critically
ill with centralised circulation, peripheral vasoconstriction,
either natural and/or due to vasoconstricting medication,
and complete absence of a pulse wave in cases fully de-
pendant on veno-arterial ECMO with continuous flow, the
assessment of the quality of peripheral perfusion can be a
major challenge, despite Doppler-ultrasonography, pulse-
oximetry, lactate levels and other adjuncts.
In conscious individuals, the information provided by the
patients themselves (absence of pain, presence of mobility
and sensitivity) are most helpful for decision making.
However, in the deeply sedated subject, it is much more
difficult to assess whether distal perfusion is adequate or
not. It has to be remembered here, that for restoring end-
organ perfusion, the window in time is quite narrow. For
the lower extremity, every effort possible has to be made to
avoid peripheral ischaemia for more than 6 hours, the tra-
ditionally accepted window for reversible ischaemia.
Therapies for limb ischaemia related
to ECLS and ECMO
The 6-hour period allowed for sufficient reperfusion has
been recently reconfirmed by Spurlock et al. [16], who
demonstrated that additional retrograde reperfusion
through the tibial artery within 6 hours avoided amputa-
tions completely, whereas the same procedure after 6 hours
was burdened with a 20% amputation rate or permanent
neurological deficit. Of course, retrograde limb perfusion
through the tibial artery is not the only limb-salvaging ap-
proach in cannula-related ischaemia of the lower extremity.
Alternative measures for re-establishing adequate anteg-
rade arterial flow include insertion of an additional arter-
ial cannula for distal perfusion, exchange of the occlud-
ing cannula for one with a smaller calibre that allows for
antegrade flow, addition of a graft for maintenance of distal
perfusion, etc. The problem with all these measures is, of
course, that in the critically ill, and this is part of the most
frequent indication for ECLS and ECMO, all additional
interventions carry a significant risk. In contrast to oth-
er clinical situations with peripheral ischaemia, there is an
additional problem in the ECLS and ECOM setting due
to the fact that the patients are usually anticoagulated to
some degree in order to prevent pump-oxygenator coagu-
lation and/or occlusion. Furthermore, there are also logistic
and practical reasons that discourage additional procedures
in ECLS- and ECMO-dependant patients, including trans-
portation to an operating theatre, a major challenge, where-
as the environment for surgery in the intensive care unit is
most of the time sub-optimal. Although wire skills for de-/
re-cannulation are helpful for a percutaneous approach, this
will also be a major challenge most of the time, because
of the complexity of the transfer of an unstable patient to a
radiology suite. Very often, a C-arm for fluoroscopy at the
bed side can be made available at best, compared with no
imaging possibility at worst.
Venous stasis due to cannulas in the femoral vessels and
venous compression due to haematomas at the cannulation
sites (personal experience) are also an issue and should not
be underestimated. Usually, the appearance of the latter is
initially less dramatic, requires more time to develop, and,
correspondingly, there seems also to be a larger time win-
dow for correction. As for other medical complications,
and this holds true for both the venous and the arterial side
[17], the prevention of their occurrence is superior to any
cure.
How to prevent limb ischaemia related
to ECLS and ECMO
Risk reduction with regard to lower extremity ischaemia
related to ECLS and ECMO is a major challenge because,
in the critically ill, it can occur without cannulation of the
femoral vessels at all. One phenomenon is known as ac-
ral necrosis and it can be, among other reasons, a result of
low cardiac output with or without vasoconstricting agents.
Having stated this, it becomes clear that the stage for lower
extremity ischaemia in ECLS and ECMO may have been
set prior to cannulation, and the latter is only the trigger to
worsen an already lost battle. As a matter of fact, lower ex-
tremity ischaemia has even been reported for patients un-
dergoing ECMO with central cannulation [12].
However, we strongly believe that a systematic approach,
taking into account the anamnesis of the patient, the ana-
tomy, the pathology, the physiology, the available perfusion
technology and the available surgical and interventional
skills, as well as the overall ECLS and ECMO strategy, has
the potential not only for risk reduction but also for im-
proved recovery.
With regard to the anamnesis, it is key to know whether a
candidate for ECLS and ECMO has any of the well-known
risk factors including vascular diseases, Raynaud’s disease,
collagenoses, coagulation disorders and heparin-induced
thrombocytopenia, to name a few. Although the risk factors
mentioned may be considered only relative contraindica-
tions for ECLS and ECMO, their accumulation does cer-
tainly not improve the prognosis.
With regard to anatomy and pathology, it is the selection
of the optimal cannulation site that can make the difference
[18, 19]. In short, it is important to allow for collateral flow
on both the arterial and the venous side, and therefore it
is recommended not to compromise the deep femoral ves-
sels. Hence the preferred level for cannula insertion into
the common femoral vessels is cephalad to the origin of the
deep femoral vessels. It goes without saying that patholo-
gical vessels segments with arteriosclerotic plaque should
be avoided whenever possible and thus ultrasonic assess-
ment of the access vessels should be routine prior to cannu-
lation.
With regard to physiology, it is recommended to place ven-
ous femoral cannulas on the contralateral side with refer-
ence to arterial femoral cannulas (fig. 2). Of course, it is
well known that the arterial cannula in the common femor-
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al artery can be occlusive or subocclusive, and the perfu-
sion of the ipsilateral lower extremity is mainly depend-
ant on collateral in-flow through the deep femoral artery
as outlined above. Likewise, venous drainage of a lower
extremity with a large venous cannula within the common
femoral vein is maintained in part by collateral out-flow
through the deep femoral vein. However, venous drain-
age through a collateral network certainly implies some de-
gree of stasis as compared with straightforward drainage
through an intact femoro-iliaco-caval axis. This venous
stasis favours oedema formation, increases the diffusion
distance and, in combination with the distal hypoperfusion
due to an ipsilateral occlusive arterial cannula, further re-
duces the arteriovenous pressure gradient. All these factors
contribute to reduced end-organ perfusion of the lower ex-
tremity with proximal cannulas in place and may result in
irreversible tissue damage. Hence, the recommendation is
to avoid whenever possible ipsilateral femoral venous can-
nulation if there is already a femoral arterial cannula in
place.
With regard to the cannulation in general, the percutaneous
approach is given preference whenever possible over open
and half-open techniques. The main reason for this recom-
mendation is the fact that some degree of long-term an-
ticoagulation is recommended/required for prevention of
pump-oxygenator thrombosis and that bleeding is one of
the most frequent complications during ECLS and ECMO,
as reported by Cheng (40.8%) [15]. Hence, any stitch and/
or incision can become the origin of a major problem dur-
ing long-lasting perfusions, which can go for weeks and
months. In contrast, the percutaneous approach derived
from the original Seldinger technique can take advantage
of the fact that any dilator or cannula inserted over the wire
has a larger diameter than the previous one and therefore
contributes to its own haemostasis by compression of the
adjacent tissue/capillaries. Indeed, a very clever approach.
Of course there are situations where the percutaneous ap-
proach is not possible or not successful, for example during
Figure 2
Schematic view of ipsilateral dual arterial cannulation and
contralateral venous cannulation just caudal to the inguinal
ligaments: systemic arterial cannulation (A) cephalad to the deep
femoral artery (+), ipsilateral second arterial cannulation (D) for
distal perfusion and contralateral venous cannulation (V) cephalad
to the deep femoral vein (*). Collateral venous drainage is possible
via the bilateral deep femoral veins (*) and the pelvic collaterals.
The same holds true for the collateral flow via the bilateral deep
femoral arteries (+). Although percutaneous cannulation on a
routine basis is preferred, an open technique is displayed here for
better identification of the femoral vessels and their branches.
cardiopulmonary resuscitation or in patients with patholo-
gical vessels, or previously catheterised, operated or oc-
cluded vessels.
With regard to the perfusion strategy, systematic antegrade
and retrograde perfusion of the cannulated access vessel is
recommended. There are several techniques to achieve this,
the most traditional one being the connection of an end-to-
side graft to the femoral vessels in order to maintain both
the proximal and the distal patent for continuous perfusion.
Unfortunately, an end-to-side anastomosis to a vessel still
requires a surgical approach and it is therefore not our pre-
ferred option. As outlined above, a fully percutaneous tech-
nique is strongly recommended, and thus the most frequent
approach on the arterial side is dual cannulation, with a
distal, ancillary cannula first, as long as distal pulsations
are palpable, and a proximal main cannula second.
It is important to mention here that the selection of the can-
nula size can be a challenge for both the antegrade and
the retrograde perfusion paths. This may seem evident for
the main systemic cannula, which is initially selected as
a function of the target flow. The latter is a function of
the problems of the patient to be bridged, and his or her
body surface area to be calculated from the height and the
bodyweight. Basically, there are three scenarios to be con-
sidered:
a) Respiratory support
b) Circulatory support
c) Combinations
Flow requirements may vary for patients requiring respir-
atory support with normal or compensatory supranormal
heart function versus patients requiring circulatory support
and combinations of the two. If the heart is arrested, full
circulatory support is necessary and unloading of the left
heart may be indicated. Likewise, for a severe white lung
syndrome, relatively high blood flows are required in order
to provide adequate gas transfer. In septic patients, even
higher flows may be necessary. In most full size adult pa-
tients a 24F arterial cannula is sufficient to provide anteg-
rade flows above the target value of 2.4 l/min/m2 for nor-
mothermic perfusion at rest, even if arterial line pressures
above 100 mm Hg may be required. Thinner arterial can-
nulas are mandatory for smaller patients and ultimately it
is the luminal width of the access vessel which determines
the maximal cannula size that can be inserted.
For perfusion of the inferior extremity dependant on the
cannulated access artery, the selection of the second smal-
ler cannula for caudal perfusion is often determined less
by flow, and more by convenience. The option of using
an introducer sheath with a side arm for this purpose, in-
stead of a paediatric arterial cannula, has been introduced
many years ago. We have used with good results a 10F
introducer sheath for this purpose. It typically adds more
than 100 ml/min additional flow to the flow provided by
the collaterals. However, it has to be mentioned here that
the flow ultimately achieved with an introducer sheet fed
by a sidearm is not only size dependant, but also dependant
on the arterial line pressure, which in turn is a function of
the pump flow, the size of the main arterial cannula, the
patient’s blood pressure, vasoconstricting medication and
other factors. In the event of doubt, use of a clamp-on flow
probe is recommended, as is routine in paediatric perfusion
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where the arterial line also feeds a haemofilter. As a matter
of fact, a no-flow situation may occur even in the presen-
ce of a second cannula, which may be stuck in a collateral.
The proof that cannula size for lower extremity perfusion
in ECLS and ECMO matters was provided by Mohite et al.
[13, 20], who reported a 30.6% ischaemia rate and a 15.4%
surgery or amputation rate for 6F to 8F introducer sheaths
in 13 patients versus 15.6% ischaemia and 6.3% surgery or
amputation rate for 10F to 12F cannulas. Hence, a 50% re-
duction of both ischaemia and surgery, respective amputa-
tion rates by using larger cannulas and thus higher flows.
Outlook
Recently, a trend to use smaller arterial cannulas that do
not require the full lumen of the access vessel and permit
parallel retrograde flow in order to maintain continuous
lower extremity perfusion has emerged. This is an interest-
ing concept because, in theory, it allows not only reduc-
tion in the number of access points with all their inher-
ent complications, but also simplification of the perfusion
circuit, the number of lines (in some cases pumps to be
supervised) and, certainly, the overall complexity of the
procedure. There can be no doubt that this is an elegant
solution in patients requiring partial support by ECLS or
ECMO. Naturally, this approach comes also at a cost. The
latter is related to the higher driving pressures required for
perfusion with arterial cannulas having a smaller luminal
width, which in turn carries the risk of excessive haemo-
lysis [21], resultant renal failure, etc. In patients requiring
Figure 3
Thin wall percutaneous cannula (top), collapsed virtually wall-less
cannula prior to insertion (centre), and virtually wall-less cannula
expanded in situ (bottom).
Figure 4
Schematic view of the concept for a new virtually wall-less cannula
designed for bidirectional flow. The performance gain achieved with
the virtually wall-less cannula design can be attributed to a short,
narrower (*), somewhat less performant cannula segment at the
point of insertion (centre), which allows not only for antegrade flow
(left), but also for some back flow in parallel towards the limb (right).
full cardiopulmonary support, i.e. with target flows of 2.4
l/min/m2 or even more as in toxic or septic shock and oth-
er life-threatening situations, a cannulation where the sys-
temic flow is restricted can become a major limitation with
severe drawbacks. It can, therefore, not be recommended
as a general strategy for routine use.
Based on the positive results with long term use of self-ex-
panding cannulas in the ECMO setting [22] and the exper-
ience in the literature showing that temporary caval filters
can be removed easily for up to 3 months [23], we explored
the potential for the development of virtually wall-less can-
nulas for the arterial side [24], allowing for bidirectional
perfusion. As a matter of fact, the performance increase
achieved with modern virtually wall-less cannula designs
(fig. 3) can be attributed not only to more flow for a given
cannula insertion diameter, but also a given target flow to
a smaller cannula diameter for the cannula access section
such that not only antegrade, but also sufficient retrograde,
flow remains possible. Figure 4 displays the concept for an
improved bidirectional cannula, with its sealed narrow seg-
ment within the access vessel allowing for retrograde flow
in parallel, and a virtually wall-less stabilising section fur-
ther downstream feeding in both directions antegrade and
retrograde. In comparison with a straight cannula with the
same access diameter, the flow limiting narrow segment of
the bidirectional design requires only a fraction of the total
cannula length and thus higher flows are possible for the
same access diameter and the same pressure drop. Early ex-
perimental assessment confirms the concept proposed.
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Figures (large format)
Figure 1
Number of reports on limb ischaemia and amputation in relation to extracorporeal membrane oxygenation (ECMO).
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Figure 2
Schematic view of ipsilateral dual arterial cannulation and contralateral venous cannulation just caudal to the inguinal ligaments: systemic
arterial cannulation (A) cephalad to the deep femoral artery (+), ipsilateral second arterial cannulation (D) for distal perfusion and contralateral
venous cannulation (V) cephalad to the deep femoral vein (*). Collateral venous drainage is possible via the bilateral deep femoral veins (*) and
the pelvic collaterals. The same holds true for the collateral flow via the bilateral deep femoral arteries (+). Although percutaneous cannulation
on a routine basis is preferred, an open technique is displayed here for better identification of the femoral vessels and their branches.
Figure 3
Thin wall percutaneous cannula (top), collapsed virtually wall-less cannula prior to insertion (centre), and virtually wall-less cannula expanded in
situ (bottom).
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Figure 4
Schematic view of the concept for a new virtually wall-less cannula designed for bidirectional flow. The performance gain achieved with the
virtually wall-less cannula design can be attributed to a short, narrower (*), somewhat less performant cannula segment at the point of insertion
(centre), which allows not only for antegrade flow (left), but also for some back flow in parallel towards the limb (right).
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